Skip to main content
HR 5668 116th Congress House Health Congressional oversight Drug safety, medical device, and laboratory regulation Prescription drugs

MODERN Labeling Act of 2020

Introduced: November 16, 2020 Introduced by: Matsui, Doris O. Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 18, 2020
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 17, 2020
Motion to reconsider laid on the table Agreed to without objection.
Nov 17, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 17, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5805-5806)
Nov 17, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 5668.
Nov 17, 2020
Considered under suspension of the rules. (consideration: CR H5805-5807)
Nov 17, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5805-5806)
Nov 16, 2020
Placed on the Union Calendar, Calendar No. 471.
Nov 16, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573.
Jul 15, 2020
Committee Consideration and Mark-up Session Held.
Jul 15, 2020
Ordered to be Reported (Amended) by Voice Vote.
Mar 11, 2020
Ordered to be Reported (Amended) by Voice Vote.
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
Jan 25, 2020
Referred to the Subcommittee on Health.
Jan 24, 2020
Referred to the House Committee on Energy and Commerce.
Jan 24, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

What's happening now November 18, 2020

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 4
  • S 1895 Related bill Lower Health Care Costs Act
  • S 1897 Related bill A bill to establish a process for updating the labeling of certain drugs with outdated labeling.
  • S 4796 Related bill Fair Care Act of 2020
  • HR 8527 Related bill Fair Care Act of 2020
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Republican 1
Taylor, Van
· Nov 16, 2020
 R
Guthrie, Brett
Kentucky · Jan 24, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5668: MODERN Labeling Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5668/
MLA
"H.R. 5668: MODERN Labeling Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5668/.
Bluebook (legal)
H.R. 5668, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5668/.
Markdown link
[H.R. 5668: MODERN Labeling Act of 2020](https://openamerica.io/bill/116-HR-5668/)
Report a problem